These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 14681842)
21. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study. Weyer C; Gottlieb A; Kim DD; Lutz K; Schwartz S; Gutierrez M; Wang Y; Ruggles JA; Kolterman OG; Maggs DG Diabetes Care; 2003 Nov; 26(11):3074-9. PubMed ID: 14578242 [TBL] [Abstract][Full Text] [Related]
22. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727 [TBL] [Abstract][Full Text] [Related]
23. An additional bolus of rapid-acting insulin to normalise postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial. Campbell MD; Walker M; Ajjan RA; Birch KM; Gonzalez JT; West DJ Diab Vasc Dis Res; 2017 Jul; 14(4):336-344. PubMed ID: 28322071 [TBL] [Abstract][Full Text] [Related]
24. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus. Burge MR; Waters DL; Holcombe JH; Schade DS J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507 [TBL] [Abstract][Full Text] [Related]
28. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target. Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603 [TBL] [Abstract][Full Text] [Related]
29. Mealtime Insulin Dosing by Carbohydrate Counting in Hospitalized Cardiology Patients: A Retrospective Cohort Study. Thurber KM; Dierkhising RA; Reiland SA; Pearson KK; Smith SA; O'Meara JG Diabetes Technol Ther; 2016 Jan; 18(1):15-21. PubMed ID: 26230278 [TBL] [Abstract][Full Text] [Related]
30. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Attia N; Jones TW; Holcombe J; Tamborlane WV Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes. Alemzadeh R; Parton EA; Holzum MK Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060 [TBL] [Abstract][Full Text] [Related]
32. Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Peters AL; Davidson MB Am J Clin Nutr; 1993 Oct; 58(4):555-60. PubMed ID: 8379513 [TBL] [Abstract][Full Text] [Related]
33. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Rabasa-Lhoret R; Bourque J; Ducros F; Chiasson JL Diabetes Care; 2001 Apr; 24(4):625-30. PubMed ID: 11315820 [TBL] [Abstract][Full Text] [Related]
34. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. Pehling G; Tessari P; Gerich JE; Haymond MW; Service FJ; Rizza RA J Clin Invest; 1984 Sep; 74(3):985-91. PubMed ID: 6381541 [TBL] [Abstract][Full Text] [Related]
35. Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. Ahola AJ; Mäkimattila S; Saraheimo M; Mikkilä V; Forsblom C; Freese R; Groop PH; J Diabetes; 2010 Sep; 2(3):194-202. PubMed ID: 20923484 [TBL] [Abstract][Full Text] [Related]
36. Effect of insulin with oral nutrients on whole-body protein metabolism in growing pubertal children with type 1 diabetes. Braziuniene I; Garlick J; Mileva I; Desikan V; Wilson TA; McNurlan M Pediatr Res; 2009 Jan; 65(1):109-12. PubMed ID: 18703999 [TBL] [Abstract][Full Text] [Related]
37. Glucose concentration in parotid saliva after glucose/food intake in individuals with glucose intolerance and diabetes mellitus. Borg Andersson A; Birkhed D; Berntorp K; Lindgärde F; Matsson L Eur J Oral Sci; 1998 Oct; 106(5):931-7. PubMed ID: 9786322 [TBL] [Abstract][Full Text] [Related]
38. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
39. Estimating insulin demand for protein-containing foods using the food insulin index. Bell KJ; Gray R; Munns D; Petocz P; Howard G; Colagiuri S; Brand-Miller JC Eur J Clin Nutr; 2014 Sep; 68(9):1055-9. PubMed ID: 25005674 [TBL] [Abstract][Full Text] [Related]
40. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. Gerich JE; Lorenzi M; Karam JH; Schneider V; Forsham PH JAMA; 1975 Oct; 234(2):159-5. PubMed ID: 1242153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]